Kim, B., Park, Y. S., Sung, J. S., Lee, J. W., Lee, S. B., & Kim, Y. H. (2020). Clathrin‐mediated EGFR endocytosis as a potential therapeutic strategy for overcoming primary resistance of EGFR TKI in wild‐type EGFR non‐small cell lung cancer. Cancer Med.

Kim, Boyeon, Young Soo Park, Jae Sook Sung, Jong Won Lee, Saet Byeol Lee, et Yeul Hong Kim. "Clathrin‐mediated EGFR Endocytosis As a Potential Therapeutic Strategy for Overcoming Primary Resistance of EGFR TKI in Wild‐type EGFR Non‐small Cell Lung Cancer." Cancer Med 2020.

Kim, Boyeon, et al. "Clathrin‐mediated EGFR Endocytosis As a Potential Therapeutic Strategy for Overcoming Primary Resistance of EGFR TKI in Wild‐type EGFR Non‐small Cell Lung Cancer." Cancer Med 2020.